2 terminated. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 2 |
| Phase 2 | 2 | Terminated 2 |
Follow Refractory T Acute Lymphoblastic Leukemia: new trials by email Literature Review of Refractory T Acute Lymphoblastic Leukemia trials Research Report on Refractory T Acute Lymphoblastic Leukemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tagraxofusp and Low-Intensity Chemotherapy for the Treatment of CD123 Positive Relapsed or Refractory Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Cyclophosphamide, Cytarabine, Dexamethasone - Recurrent Adult Lymphoblastic Lymphoma, Recurrent B Acute Lymphoblastic Leukemia | Phase 1 / Phase 2 | Terminated | M.D. Anderson Cancer Center | 4 | 2022-02-17 | 2025-08-11 |
| Low-Intensity Chemotherapy and Venetoclax in Treating Patients With Relapsed or Refractory B- or T-Cell Acute Lymphoblastic Leukemia Cyclophosphamide, Cytarabine, Dexamethasone - Recurrent B Acute Lymphoblastic Leukemia, Recurrent T Acute Lymphoblastic Leukemia | Phase 1 / Phase 2 | Terminated | M.D. Anderson Cancer Center | 53 | 2019-04-03 | 2026-05-13 |
Burkitt Lymphoma (2) · Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (2) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
DNA Virus Infections (2) · Epstein-Barr Virus Infections (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Herpesviridae Infections (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Infections (2) · Leukemia (2) · Leukemia, Lymphoid (2) · Lymphatic Diseases (2) · Lymphoma (2) · Lymphoma, B-Cell (2) · Lymphoma, Non-Hodgkin (2) · Lymphoproliferative Disorders (2)
CT-P10 (2) · Calcium Dobesilate (2) · Cyclophosphamide (2) · Cytarabine (2) · Dexamethasone (2) · Methotrexate (2) · Prednisone (2) · Rituximab (2) · Vincristine (2) · auricularum (2) · deltacortene (2) · dexamethasone 21-phosphate (2) · dexamethasone acetate (2) · merphos (2) · prednylidene (2)
M.D. Anderson Cancer Center (2)
United States (2)
Elias Jabbour (1) · Nicholas Short, MD (1)